Maki Kobayashi
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 7
- Pancreatic and Hepatic Oncology Research 6
-
- Lung Cancer Treatments and Mutations 6
- Gastric Cancer Management and Outcomes 5
-
- Intracranial Aneurysms: Treatment and Complications 7
-
- Phytoestrogen effects and research 6
-
- Cardiovascular Function and Risk Factors 6
Maki Kobayashi
63 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 111
- Oncology 519
- Immunology 212
- Pulmonary and Respiratory Medicine 236
- Cancer Research 99
- Epidemiology 187
Countries citing papers authored by Maki Kobayashi
This map shows the geographic impact of Maki Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Kobayashi more than expected).
Fields of papers citing papers by Maki Kobayashi
This network shows the impact of papers produced by Maki Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Kobayashi. The network helps show where Maki Kobayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maki Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 1 | |
| 8 | 2019 | 19 | |
| 9 | 2019 | 3 | |
| 10 | 2018 | 21 | |
| 11 | 2018 | 11 | |
| 12 | 2018 | 6 | |
| 13 | 2018 | 20 | |
| 14 | 2016 | 16 | |
| 15 | 2016 | 4 | |
| 16 | 2013 | 3 | |
| 17 | 2012 | 4 | |
| 18 | 2011 | 105 | |
| 19 | 2011 | 5 | |
| 20 | 2010 | 53 |
About Maki Kobayashi
Maki Kobayashi is a scholar working on Oncology, Neurology and Pulmonary and Respiratory Medicine, having authored 77 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Intracranial Aneurysms: Treatment and Complications (7 papers), Lung Cancer Research Studies (7 papers), Pancreatic and Hepatic Oncology Research (6 papers), Phytoestrogen effects and research (6 papers), Cardiovascular Function and Risk Factors (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Oncology (519 citations), Immunology (212 citations) and Pulmonary and Respiratory Medicine (236 citations). Maki Kobayashi has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Kentaro Inamura, Yuichi Ishikawa, Yusuke Yokouchi, Sakae Okumura, Hironori Ninomiya, Rie Sakakibara, Hiroko Nagano, Tomoko Shibutani, Mitsuru Fukuda and Kimie Nomura. Their work appears in journals such as Neurologia medico-chirurgica, Scientific Reports, Heart and Vessels, World Neurosurgery and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.